alcaftadine Eye drops 0.25 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.

Manufacturer usually replies in 22 days

Alcaftadine is a medication used to treat eye irritation caused by allergic conjunctivitis. The manufacturer and sole supplier of alcaftadine is Allergan, who first introduced it into the market in 2010 under the trade name Lastacaft. It is made available in the form of ophthalmic drops. Pharmaceutical specialists are welcome to browse through offers of alcaftadine tablets from suppliers on our pharmaceutical marketplace, or else seek out further useful medical information about alcaftadine online, at the official Lastacaft product website.